[{"Assets_0_FY_USD":4166092000.0,"CommonStockSharesOutstanding_0_FY_shares":164400717.0,"EarningsPerShareBasic_1_FY_USD":-0.28,"EarningsPerShareBasic_4_FY_USD":-2.52,"EarningsPerShareDiluted_1_FY_USD":-0.28,"EarningsPerShareDiluted_4_FY_USD":-2.52,"NetIncomeLoss_4_FY_USD":-410526000.0,"StockholdersEquity_0_FY_USD":991098000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":163122663.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":163122663.0,"Ticker":"HZNP","CIK":"1492426","name":"HORIZON PHARMA PLC","OfficialName":"Horizon Therapeutics Public Limited Company Ordinary Shares","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"26299872538.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180228"}]